Latest kidney cancer news
Europe has approved subcutaneous nivolumab for solid tumours
The Committee for Medicinal Products for Human Use (CHMP) of [...]
The Big Cancer52 Conversation
Earlier this week, Sharon Deveson Kell represented kidney cancer patients [...]
A urine test to detect the return of kidney cancer
A study has shown that a simple urine test could [...]
Spotting symptoms early: the importance of early diagnosis
Cancer Research UK have been highlighting the importance of screening [...]
Health-related quality of life with belzutifan versus everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
Combinations of pembrolizumab and targeted therapies for advanced clear cell kidney cancer
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib cabozantinib Sutent kidney cancer progression-free survival NHS England biomarkers ipilimumab pembrolizumab Cabometyx COVID-19 axitinib cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus Yervoy risk factors adjuvant therapy Keytruda metastases targeted therapy papillary RCC everolimus biological markers ASCO Afinitor cancer outcomes first-line treatment NICEArchives
- 2025: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
